A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome

Matthew E. Nielsen, Ganesh S. Palapattu, Pierre I. Karakiewicz, Yair Lotan, Patrick J. Bastian, Seth P. Lerner, Arthur I. Sagalowsky, Mark P. Schoenberg, Shahrokh F. Shariat

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

OBJECTIVE: To examine the association between the interval from the last transurethral resection (TUR) to radical cystectomy (RC) and bladder cancer-specific outcome, as the decision to proceed to RC for an individual patient is complex, and recent reports suggest an interval from diagnosis to RC of >3 months is associated with adverse outcomes. PATIENTS AND METHODS: The records of 592 patients who had RC were reviewed; the interval from the last TUR was analysed as both a continuous and categorical variable (<3 vs ≥3 months). Logistic regression and survival analyses were used to evaluate the association between the interval to RC with pathological characteristics and clinical outcomes. RESULTS: The mean (sd) actuarial cancer-specific survival was 70.5 (2.3)% and 60.7 (3.2)% at 3 and 7 years, respectively. Overall, the median (range) time from TUR to RC was 1.8 (0.3-11.6) months. The interval to RC analysed as a continuous or categorical variable was not associated with extravesical or nodal disease, lymph node metastases, disease recurrence, overall or cancer-specific survival. The results were similar in the subgroup of 320 patients (54%) with clinically muscle-invasive disease. CONCLUSIONS: These results suggest that a reasonable delay from the last TUR to RC is not independently associated with stage progression or with decreased recurrence-free or disease-specific survival. These findings might have important implications for trial design in the ongoing evaluation of neoadjuvant regimens. Nevertheless, we see no reason to advocate anything less than the timely consideration of definitive treatment for patients with high-risk bladder cancer.

Original languageEnglish (US)
Pages (from-to)1015-1020
Number of pages6
JournalBJU International
Volume100
Issue number5
DOIs
StatePublished - Nov 2007
Externally publishedYes

Fingerprint

Cystectomy
Urinary Bladder Neoplasms
Survival
Recurrence
Survival Analysis
Neoplasms
Logistic Models
Lymph Nodes
Regression Analysis
Neoplasm Metastasis
Muscles

Keywords

  • Bladder cancer
  • Cystectomy
  • Recurrence
  • Stage
  • Survival
  • Time

ASJC Scopus subject areas

  • Urology

Cite this

Nielsen, M. E., Palapattu, G. S., Karakiewicz, P. I., Lotan, Y., Bastian, P. J., Lerner, S. P., ... Shariat, S. F. (2007). A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome. BJU International, 100(5), 1015-1020. https://doi.org/10.1111/j.1464-410X.2007.07132.x

A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome. / Nielsen, Matthew E.; Palapattu, Ganesh S.; Karakiewicz, Pierre I.; Lotan, Yair; Bastian, Patrick J.; Lerner, Seth P.; Sagalowsky, Arthur I.; Schoenberg, Mark P.; Shariat, Shahrokh F.

In: BJU International, Vol. 100, No. 5, 11.2007, p. 1015-1020.

Research output: Contribution to journalArticle

Nielsen, ME, Palapattu, GS, Karakiewicz, PI, Lotan, Y, Bastian, PJ, Lerner, SP, Sagalowsky, AI, Schoenberg, MP & Shariat, SF 2007, 'A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome', BJU International, vol. 100, no. 5, pp. 1015-1020. https://doi.org/10.1111/j.1464-410X.2007.07132.x
Nielsen ME, Palapattu GS, Karakiewicz PI, Lotan Y, Bastian PJ, Lerner SP et al. A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome. BJU International. 2007 Nov;100(5):1015-1020. https://doi.org/10.1111/j.1464-410X.2007.07132.x
Nielsen, Matthew E. ; Palapattu, Ganesh S. ; Karakiewicz, Pierre I. ; Lotan, Yair ; Bastian, Patrick J. ; Lerner, Seth P. ; Sagalowsky, Arthur I. ; Schoenberg, Mark P. ; Shariat, Shahrokh F. / A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome. In: BJU International. 2007 ; Vol. 100, No. 5. pp. 1015-1020.
@article{fa215f92f6e1414190d91537d0720078,
title = "A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome",
abstract = "OBJECTIVE: To examine the association between the interval from the last transurethral resection (TUR) to radical cystectomy (RC) and bladder cancer-specific outcome, as the decision to proceed to RC for an individual patient is complex, and recent reports suggest an interval from diagnosis to RC of >3 months is associated with adverse outcomes. PATIENTS AND METHODS: The records of 592 patients who had RC were reviewed; the interval from the last TUR was analysed as both a continuous and categorical variable (<3 vs ≥3 months). Logistic regression and survival analyses were used to evaluate the association between the interval to RC with pathological characteristics and clinical outcomes. RESULTS: The mean (sd) actuarial cancer-specific survival was 70.5 (2.3){\%} and 60.7 (3.2){\%} at 3 and 7 years, respectively. Overall, the median (range) time from TUR to RC was 1.8 (0.3-11.6) months. The interval to RC analysed as a continuous or categorical variable was not associated with extravesical or nodal disease, lymph node metastases, disease recurrence, overall or cancer-specific survival. The results were similar in the subgroup of 320 patients (54{\%}) with clinically muscle-invasive disease. CONCLUSIONS: These results suggest that a reasonable delay from the last TUR to RC is not independently associated with stage progression or with decreased recurrence-free or disease-specific survival. These findings might have important implications for trial design in the ongoing evaluation of neoadjuvant regimens. Nevertheless, we see no reason to advocate anything less than the timely consideration of definitive treatment for patients with high-risk bladder cancer.",
keywords = "Bladder cancer, Cystectomy, Recurrence, Stage, Survival, Time",
author = "Nielsen, {Matthew E.} and Palapattu, {Ganesh S.} and Karakiewicz, {Pierre I.} and Yair Lotan and Bastian, {Patrick J.} and Lerner, {Seth P.} and Sagalowsky, {Arthur I.} and Schoenberg, {Mark P.} and Shariat, {Shahrokh F.}",
year = "2007",
month = "11",
doi = "10.1111/j.1464-410X.2007.07132.x",
language = "English (US)",
volume = "100",
pages = "1015--1020",
journal = "BJU International",
issn = "1464-4096",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome

AU - Nielsen, Matthew E.

AU - Palapattu, Ganesh S.

AU - Karakiewicz, Pierre I.

AU - Lotan, Yair

AU - Bastian, Patrick J.

AU - Lerner, Seth P.

AU - Sagalowsky, Arthur I.

AU - Schoenberg, Mark P.

AU - Shariat, Shahrokh F.

PY - 2007/11

Y1 - 2007/11

N2 - OBJECTIVE: To examine the association between the interval from the last transurethral resection (TUR) to radical cystectomy (RC) and bladder cancer-specific outcome, as the decision to proceed to RC for an individual patient is complex, and recent reports suggest an interval from diagnosis to RC of >3 months is associated with adverse outcomes. PATIENTS AND METHODS: The records of 592 patients who had RC were reviewed; the interval from the last TUR was analysed as both a continuous and categorical variable (<3 vs ≥3 months). Logistic regression and survival analyses were used to evaluate the association between the interval to RC with pathological characteristics and clinical outcomes. RESULTS: The mean (sd) actuarial cancer-specific survival was 70.5 (2.3)% and 60.7 (3.2)% at 3 and 7 years, respectively. Overall, the median (range) time from TUR to RC was 1.8 (0.3-11.6) months. The interval to RC analysed as a continuous or categorical variable was not associated with extravesical or nodal disease, lymph node metastases, disease recurrence, overall or cancer-specific survival. The results were similar in the subgroup of 320 patients (54%) with clinically muscle-invasive disease. CONCLUSIONS: These results suggest that a reasonable delay from the last TUR to RC is not independently associated with stage progression or with decreased recurrence-free or disease-specific survival. These findings might have important implications for trial design in the ongoing evaluation of neoadjuvant regimens. Nevertheless, we see no reason to advocate anything less than the timely consideration of definitive treatment for patients with high-risk bladder cancer.

AB - OBJECTIVE: To examine the association between the interval from the last transurethral resection (TUR) to radical cystectomy (RC) and bladder cancer-specific outcome, as the decision to proceed to RC for an individual patient is complex, and recent reports suggest an interval from diagnosis to RC of >3 months is associated with adverse outcomes. PATIENTS AND METHODS: The records of 592 patients who had RC were reviewed; the interval from the last TUR was analysed as both a continuous and categorical variable (<3 vs ≥3 months). Logistic regression and survival analyses were used to evaluate the association between the interval to RC with pathological characteristics and clinical outcomes. RESULTS: The mean (sd) actuarial cancer-specific survival was 70.5 (2.3)% and 60.7 (3.2)% at 3 and 7 years, respectively. Overall, the median (range) time from TUR to RC was 1.8 (0.3-11.6) months. The interval to RC analysed as a continuous or categorical variable was not associated with extravesical or nodal disease, lymph node metastases, disease recurrence, overall or cancer-specific survival. The results were similar in the subgroup of 320 patients (54%) with clinically muscle-invasive disease. CONCLUSIONS: These results suggest that a reasonable delay from the last TUR to RC is not independently associated with stage progression or with decreased recurrence-free or disease-specific survival. These findings might have important implications for trial design in the ongoing evaluation of neoadjuvant regimens. Nevertheless, we see no reason to advocate anything less than the timely consideration of definitive treatment for patients with high-risk bladder cancer.

KW - Bladder cancer

KW - Cystectomy

KW - Recurrence

KW - Stage

KW - Survival

KW - Time

UR - http://www.scopus.com/inward/record.url?scp=35148861776&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35148861776&partnerID=8YFLogxK

U2 - 10.1111/j.1464-410X.2007.07132.x

DO - 10.1111/j.1464-410X.2007.07132.x

M3 - Article

VL - 100

SP - 1015

EP - 1020

JO - BJU International

JF - BJU International

SN - 1464-4096

IS - 5

ER -